| INTRODUC TI ON
Hypoparathyroidism is a rare, complex endocrine disorder resulting from undetectable or inappropriately low levels of parathyroid hormone (PTH). 1, 2 Deficiency of PTH, the principal regulator of calcium and phosphate homeostasis, results in the hallmark biochemical abnormalities of hypocalcaemia and hyperphosphataemia. 3 Conventional management of hypoparathyroidism consists of treatment with activated vitamin D analogues and calcium supplements. 1 However, conventional therapy does not replace other functions of PTH to restore physiological mineral homeostasis, resulting in a potential increased risk of physical symptoms, including fatigue, paraesthesia, muscle cramping, tetany, and joint or bone pain, 4, 5 and of long-term complications, such as soft-tissue calcifications and impaired renal function. 2, 4, 6, 7 For some patients with chronic hypoparathyroidism, a managed transition from a high daily calcium intake to a no calcium (or lower calcium) treatment regimen may reduce adverse events or complications, including kidney stones and hospitalization due to hyper-or hypocalcaemia. 8 In addition, chronic hypoparathyroidism is associated with cognitive and emotional symptoms such as mental lethargy, inability to concentrate, memory loss or forgetfulness, anxiety and depression. 5 The negative impact of chronic hypoparathyroidism on health-related quality of life (HRQoL) has been documented 5, [9] [10] [11] [12] ; however, significant knowledge gaps exist regarding the overall burden of illness associated with chronic hypoparathyroidism, including symptom severity, impact on activities of daily living and caregiver burden, particularly among patients who are not adequately controlled on conventional therapy. In a US-based survey of 374 patients with hypoparathyroidism, 79% of respondents strongly agreed that most physicians do not understand hypoparathyroidism, leading to the perception of an 'empathy gap' between healthcare providers and patients. 5 In addition, Cho et al 13 reported that surgeons underestimate potential complications and the negative impact on quality of life (QoL) associated with postsurgical hypoparathyroidism, compared with patients' own perceptions. To address the scarcity of data regarding the specific burdens imposed by not adequately controlled chronic hypoparathyroidism on patients and their caregivers, we conducted a global survey to characterize the burden of not adequately controlled chronic hypoparathyroidism and its impact on HRQoL from the patient and, for the first time, the caregiver perspectives. An 
| MATERIAL S AND ME THODS

| Study design
| Study populations
| Patients
Patients were eligible to participate if they were aged ≥18 years, had a confirmed diagnosis of chronic hypoparathyroidism for ≥12 months, were currently receiving conventional therapy for hypoparathyroidism, and their disease was not adequately controlled.
Not adequately controlled hypoparathyroidism was determined by patients' report of persistent symptoms and/or poorly controlled or ; were diagnosed with pseudohypoparathyroidism; or had completed a survey assessing the burden of hypoparathyroidism within the past 3 months.
| Caregivers
Caregivers were eligible to participate if they were aged ≥18 years, provided unpaid care for a spouse/partner, son/daughter, parent, sibling, other relative, friend/neighbour or other person completing the patient survey, and were the primary caregiver to a patient with hypoparathyroidism. Professional caregivers providing paid care were excluded.
| Outcomes
Patients' hypoparathyroidism-associated symptoms were evaluated using the Hypoparathyroidism Symptom Diary, a disease-specific, patient-reported outcome tool that records the severity of symptoms and impacts experienced in the past 7 days. 14 zero (equivalent to death) and one (full health). 16, 17 The EQ-5D-5L includes the EQ Visual Analogue Scale (EQ VAS), which provides a quantitative measure of health perception by asking patients to rate their overall health on a 20-cm vertical, visual analogue scale, ranging from zero (worst possible health) to 100 (best possible health). 16 Patient employment status and productivity were evaluated using the validated Work Productivity and Activity Impairment 
| Statistical methods
All analyses were descriptive. No statistical testing was performed.
Where missing data occurred in the pen and paper survey, data points were omitted from data entry and the individual survey was assessed for the validity of remaining data points. The total number of patients and caregivers available for analysis differed among variables owing to missing data because some patients and caregivers did not respond to all questions in the survey. There were no missing data from the electronic survey because respondents could have selected 'don't know' or 'other' as a response. the greatest differences between these cohorts were observed for sex (92% and 70% women, respectively) and the percentage of patients who had been told by a physician that their serum calcium levels are poorly controlled (45% and 80%, respectively).
| RE SULTS
| Patient and caregiver disposition and demographics, and patient disease characteristics
| Hypoparathyroidism-related symptoms and impacts as reported by patients
Findings from the Hypoparathyroidism Diary are shown in Table 2 .
According to the Hypoparathyroidism Symptom Diary (n = 397), the percentage of patients reporting moderate, severe and very severe symptoms over a 7-day recall period was 73% for physical fatigue (n = 289), 55% for muscle cramps (n = 217), 55% for heaviness in limbs (n = 219), 51% for tingling (n = 201), 48% for numbness (n = 189), 47%
for muscle spasms or twitching (n = 188), 47% for slow or confused thinking (n = 186), 46% for anxiety (n = 183) and 41% for sadness or depression (n = 161). Impacts rated as 'somewhat' or 'very much'
(n = 397) were reported by 84% of patients for ability to exercise, 78%
for sleep, 75% for ability to work and 63% for family relationships.
| Patient health-related quality of life and health status
There was an inverse relationship between patient self-rated overall hypoparathyroidism symptom severity and both the HRQoL and health status assessment scores: the higher the severity level, the lower the HRQoL and health status scores. EQ-5D-5L utility scores were 0.9/0.8/0.7/0.4 and EQ-5D-5L EQ VAS scores were 86.9/72.5/57.7/41.1 for patients reporting no/mild/moderate/ severe hypoparathyroidism symptoms, respectively ( Figure 1A,B) . Figure 2 ). There were no notable differences in SF-36 scores between patients recruited through patient associations or via physicians; the mean PCS score for patients recruited through patient associations (n = 141) was 36.0 (range: 14-61) and for physician-recruited patients (n = 257) was 40.2 (range: 16-60). Likewise, the mean MCS score was 37.9 (range: 11-60) for patients recruited through patient associations and 38.7 (range: 10-66) for patients recruited through physicians. 
| Medication and pill burden associated with chronic hypoparathyroidism
| Impact on patient and caregiver employment and productivity
Of 397 patients, the percentage with full-time work decreased from 58% before the diagnosis of hypoparathyroidism to 34% at the time [n = 25]). WPAI scores reflected patients working and conducting activities at 59% and 58% of their full capacity, respectively. Overall, work impairment and activity impairment were greater with increased patient self-rated symptom severity. Work impairment was reported by 18%, 28%, 49% and 68% of employed patients; likewise activity impairment was reported by 24%, 34%, 57% and 76% of employed patients (n = 190) reporting no (n = 5), mild (n = 79), moderate (n = 91) and severe (n = 15) symptoms, respectively.
The proportion of caregivers with full-time work decreased from 51% (n = 106) before the hypoparathyroidism diagnosis to 41% (n = 84) at the time of survey (Table 3 ). Among caregivers who changed their employment status (n = 42), 26% (n = 11) attributed the change to caregiving for a patient with hypoparathyroidism. 
| Impact on patient and caregiver relationships, and caregiver burden
The percentage of patients reporting a major impact on relationships increased with self-rated symptom severity ( Figure 3A) . Patients who self-rated as having no symptoms of hypoparathyroidism did not report a major impact on any relationship, whereas a majority of patients who self-rated as having severe symptoms of hypoparathyroidism reported a major impact on relationships with spouses/ partners, family and friends. Caregivers also reported that hypoparathyroidism had a major impact on their relationships, with their relationships with their spouse/partner affected the most (n = 57/206; 28%) ( Figure 3B) . Overall, the mean MCSI score for caregivers was 7.8; however, caregiver strain increased with the increasing severity of the patient's symptoms as rated by the caregiver (no symptoms, 1.7; mild, 5.4; moderate, 9.5; and severe, 12.5). Recent studies have examined the consequences of hypoparathyroidism on multiple aspects of a patient's personal and social life while receiving conventional therapy. [9] [10] [11] [12] [13] 20 In particular, five studies utilized the SF-36 instrument to evaluate HRQoL in patients with hypoparathyroidism receiving conventional therapy compared with a reference population or control subjects. [10] [11] [12] [13] 20 Two of these studies reported significantly reduced scores in most or all SF-36 domains among patients with chronic, postsurgical hypoparathyroidism or nonsurgical hypoparathyroidism, compared with a normbased US population. 10, 12 Two further studies, one Danish and one Norwegian, showed significantly lower SF-36 domain scores, in patients with hypoparathyroidism compared with controls. 11, 20 Cho selected controls should be more comparable to the patients with chronic hypoparathyroidism-ideally, patients who have undergone surgery for thyroid or parathyroid disease. [9] [10] [11] [12] [13] 20 Mean SF-36 PCS and MCS scores reported for patients with hypoparathyroidism in this survey were generally comparable to or lower than scores reported for patients with other long-term disease states, such as heart disease, [21] [22] [23] haematologic disorders, 24, 25 diabetes 26, 27 and cancer. [28] [29] [30] [31] Although the HRQoL impact of hypoparathyroidism is on a par with other chronic conditions considered to have a substantial burden of illness, physicians and the general F I G U R E 3 Major impact of hypoparathyroidism on (A) patient relationships categorized by self-rated hypoparathyroidism symptom severity* (N = 396 † ) and (B) caregiver relationships (N = 207 ‡ ). * None of the patients' self-rating as having no symptoms of hypoparathyroidism (n = 11) reported a major impact on any personal relationship. † n = 395 for relationships with family, friends and children. ‡ n = 206 for relationship with spouse/partner public can underestimate the consequences of hypoparathyroidism for patients. 5, 13 These findings underscore the debilitating nature of chronic hypoparathyroidism, a disorder that impacts both mental and physical dimensions in the life of a patient, and will contribute towards a better understanding of the burden of illness and improving outcomes for both patient and caregiver.
| D ISCUSS I ON
It is noteworthy that receptors for the parathyroid hormone are expressed in muscle, spinal cord and several brain regions. 32, 33 It is plausible that a deficiency of parathyroid hormone in these tissues contributes to the reduced HRQoL beyond its effects on disrupted mineral homeostasis, particularly in aspects related to mental and emotional health and vitality. 34 
| CON CLUS IONS
Findings from this multicountry survey reflected a broad spectrum of symptom severity within a cohort of patients with not adequately controlled hypoparathyroidism. The magnitude of symptom severity as reported by patients was inversely proportional to HRQoL and health status scores. Strikingly, the impact of chronic hypoparathyroidism on HRQoL was similar to or more pronounced than for other severe chronic diseases. Most patients reported a high pill burden that correlated with their overall symptom severity. In addition to cognitive, emotional and physical symptoms, patients experienced an interference with the activities of daily living, employment and personal relationships. Caregivers also experienced caregiver strain and decreased work productivity that corresponded with caregiver perception of the patient's symptom severity. These findings highlight the substantial impaired HRQoL resulting from burdensome hypoparathyroidism-related symptoms, and impact in daily living and activities in patients with chronic hypoparathyroidism and the attendant burden on their caregivers. HD-H has no conflicts to report.
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